A cohort study finds that hydroxychloroquine use in cutaneous lupus erythematosus reduces the risk of developing systemic ...
While side effects of corticosteroids are usually to blame, there is also the possibility of ocular damage associated with long-term use of the antimalarial drugs hydroxychloroquine (brand name: ...
Up to 50% of lupus patients may have non-life threatening symptoms such as fatigue, joint pain, and rash. Non-steroidal anti-inflammatories (e.g. ibuprofen) and antimalarials (Plaquenil) are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results